Goldman Sachs
BDSX icon

Goldman Sachs’s Biodesix BDSX Stock Holding History

Goldman Sachs’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,105
Closed -$13.8K – 6086
2025
Q1 		$13.8K Sell
1,105
-4,797
-81% -$92.1K ﹤0.01% 5959
2024
Q4 		$181K Buy
+5,902
New +$174K ﹤0.01% 5671
2024
Q2 		– Sell
-1,377
Closed -$39.4K – 5655
2024
Q1 		$39.4K Buy
+1,377
New +$47.1K ﹤0.01% 5341
2022
Q3 		– Sell
-543
Closed -$18K – 6260
2022
Q2 		$18K Buy
+543
New +$17.7K ﹤0.01% 6192
2021
Q3 		– Sell
-777
Closed -$205K – 6229
2021
Q2 		$205K Buy
777
+193
+33% +$60.7K ﹤0.01% 5728
2021
Q1 		$237K Sell
584
-316
-35% -$141K ﹤0.01% 5562
2020
Q4 		$363K Buy
+900
New +$280K ﹤0.01% 4791

Other funds holding BDSX

TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Goldman Sachs's BDSX Position: Q2 2025 in Review

Goldman Sachs sold out of Biodesix (BDSX) in Q2 2025, closing a stake of 1,105 shares — an estimated $13.8K sold.

Goldman Sachs first reported a position in BDSX in Q4 2020 and held it in 7 quarters. The position peaked at $363K in Q4 2020. 40 funds tracked by Wall St. Rank hold BDSX as of Q2 2025.

  • Goldman Sachs reported no remaining Biodesix position as of Q2 2025 after selling out during the quarter.
  • Goldman Sachs sold 1,105 Biodesix shares in Q2 2025, an estimated $13.8K.
  • Goldman Sachs first reported a position in Biodesix in Q4 2020 and held it in 7 quarters.
  • Goldman Sachs's Biodesix position peaked at $363K in Q4 2020.
  • 40 funds tracked by Wall St. Rank held Biodesix as of Q2 2025.

Based on Goldman Sachs's 13F filing for Q2 2025, filed 14 Aug 2025.